|
|
|
|
The Five Warning Signs of Alzheimer's Disease
Nancy Travers You visited your parents recently and your mom's behavior worried you.She didn't seem her usual self - she was forgetful, repeating herself in conversation and over the weekend she seemed to misplace more items than is usual. You want to just...
|
|
|
Medivation Reports Fourth Quarter and Year-End 2009 Financial Results and Provides Corporate Update
SAN FRANCISCO, March 15 /PRNewswire-FirstCall/ -- Medivation, Inc.(NASDAQ:MDVN) today provided a corporate update and reported its financial results for the year ended December 31, 2009. 'We are disappointed by the results of the Phase 3 CONNECTION trial...
|
|
|
Senior News: Social Security initiative helps early-onset Alzheimer's patients
The Social Security Administration has added early-onset (younger-onset) Alzheimer's disease to its Compassionate Allowances Initiative, which will allow people under age 65, diagnosed with Alzheimer's, to apply for and receive benefits.The initiative...
|
|
|
Bristol's Early Alzheimer's Research Takes A Different Tack
Remember Me Already a subscriber?Sign in or register to create an account? Search Include Synonyms PUBLICATIONS: Check All | Uncheck All 'The Pink Sheet' 'The Rose Sheet' Pharmaceutical Approvals Monthly 'The Gold Sheet' 'The Gray Sheet' Health News Daily ...
|
|
|
European orphan drug status for Allon's neuroprotective drug candidate davunetide
Allon Therapeutics Inc.announced that its lead neuroprotective drug candidate, davunetide, has been granted Orphan Drug Status in the European Union (EU) for the treatment of Progressive Supranuclear Palsy (PSP), a rapidly-progressing and fatal degenerative...
|
|
|
Brain plaques may explain higher risk of Alzheimer's based on mom's history
Two views of a composite image of the brains analyzed in the study compare the average increases in amyloid-beta deposits in volunteers with a maternally or paternally inherited risk of Alzheimer's, compared to counterparts with no family history of dementia.
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
PHILADELPHIA, March 18 /PRNewswire-USNewswire/ -- The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug...
|
|
|
TopAbstracts in Alzheimer's 03/18/2010
TopAbstracts in Alzheimer's are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.Over 2000 peer-reviewed journals are...
|
|
|
Art stimulates conversation with Alzheimer's patients
Jeanne Quigley of Alzheimers Services of Cape Cod and the Islands talks about art by Guyer Barn last week.Cape Cod Times/Merrily Lunsford One of the first things that Alzheimer's disease robs an individual of is the ability to remember words and...
|
|
|
Mental Health 101: Where can I find neurologists in New York for dementia and Alzheimers disease
Mental Health 101: Where can I find neurologists in New York for dementia and Alzheimer's disease March 17, 11:19 PMNY Healthy Living ExaminerMarmee Cosico Comment Subscribe Get alerts when there is a new article from the NY Healthy Living Examiner.
|
|
|
Alzheimer's disease: Gene expression level influences promotion of disorder or protection against development
Researchers believe it's not enough to look for disease risk genes -- understanding expression levels of genes is important, too Using sophisticated techniques that scan the genomes of patients, researchers at the Mayo Clinic campus in Florida have found that a...
|
|
|
J&J rattles analysts with long delay for Alzheimer's program
J&J has rattled analysts with a new timeline for the Alzheimer's drug bapineuzumab, saying that full, late-stage results for the closely-watched therapy may not be available for two years.'We are conducting some of the largest-scale trials ever in ...
|
|
|
Law Offices of Howard G. Smith, Representing Investors of Medivation, Inc., Announces Class Action Lawsuit
- Law Offices of Howard G.Smith, representing investors of Medivation, Inc. (Medivation or the Company) (Nasdaq:MDVN), has filed a class action lawsuit in United States District Court on behalf of a class (the Class) consisting of all persons or entities...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
LIFE SCIENCES: Bapineuzumab results not expected until 2012
Johnson & Johnson has announced that the eagerly anticipated full late-stage results for the Alzheimer's drug bapineuzumab will be two years later than expected.Johnson & Johnson took over the development of the drug when it bought Elan's ...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzhe
PHILADELPHIA Initially, the collaboration between Penn Medicine and AstraZeneca scientists will focus on generating new Alzheimer's disease (AD) drug candidates for the clinical development pipeline.In AD, the formation of amyloid plaques and...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
PHILADELPHIA, March 18 /PRNewswire-USNewswire/ -- The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug...
|
